Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 30

1.

Regulation of CD95/Fas signaling at the DISC.

Lavrik IN, Krammer PH.

Cell Death Differ. 2012 Jan;19(1):36-41. doi: 10.1038/cdd.2011.155. Epub 2011 Nov 11. Review.

2.

Nonapoptotic functions of FADD-binding death receptors and their signaling molecules.

Park SM, Schickel R, Peter ME.

Curr Opin Cell Biol. 2005 Dec;17(6):610-6. Epub 2005 Oct 13. Review.

PMID:
16226446
3.

c-FLIP, a master anti-apoptotic regulator.

Safa AR.

Exp Oncol. 2012 Oct;34(3):176-84. Review.

4.

[Regulation of death receptor-induced apoptosis induced via CD95/FAS and other death receptors].

Lavrik IN.

Mol Biol (Mosk). 2011 Jan-Feb;45(1):173-9. Review. Russian.

PMID:
21485506
5.

The multilevel regulation of CD95 signaling outcome.

Yurchenko M, Shlapatska LM, Sidorenko SP.

Exp Oncol. 2012 Oct;34(3):153-9. Review.

PMID:
23069999
6.

Ripped to death.

Weinlich R, Dillon CP, Green DR.

Trends Cell Biol. 2011 Nov;21(11):630-7. doi: 10.1016/j.tcb.2011.09.002. Epub 2011 Oct 4. Review.

7.

Systems biology of death receptor networks: live and let die.

Lavrik IN.

Cell Death Dis. 2014 May 29;5:e1259. doi: 10.1038/cddis.2014.160. Review.

8.

RIPK-dependent necrosis and its regulation by caspases: a mystery in five acts.

Green DR, Oberst A, Dillon CP, Weinlich R, Salvesen GS.

Mol Cell. 2011 Oct 7;44(1):9-16. doi: 10.1016/j.molcel.2011.09.003. Review.

9.

Death effector domain-containing proteins.

Valmiki MG, Ramos JW.

Cell Mol Life Sci. 2009 Mar;66(5):814-30. doi: 10.1007/s00018-008-8489-0. Review.

PMID:
18989622
10.

Targeting c-FLICE-like inhibitory protein (CFLAR) in cancer.

Fulda S.

Expert Opin Ther Targets. 2013 Feb;17(2):195-201. doi: 10.1517/14728222.2013.736499. Epub 2012 Dec 20. Review.

PMID:
23252466
11.

FLASH meets nuclear bodies: CD95 receptor signals via a nuclear pathway.

Krieghoff E, Milovic-Holm K, Hofmann TG.

Cell Cycle. 2007 Apr 1;6(7):771-5. Epub 2007 Apr 21. Review.

PMID:
17377497
12.

Death effecter domain for the assembly of death-inducing signaling complex.

Yang JK.

Apoptosis. 2015 Feb;20(2):235-9. doi: 10.1007/s10495-014-1060-6. Review.

PMID:
25451007
13.

Principles and mechanisms of CD95 activation.

Wajant H.

Biol Chem. 2014 Dec;395(12):1401-16. doi: 10.1515/hsz-2014-0212. Review.

PMID:
25153377
14.

Characterization of the ripoptosome and its components: implications for anti-inflammatory and cancer therapy.

Schilling R, Geserick P, Leverkus M.

Methods Enzymol. 2014;545:83-102. doi: 10.1016/B978-0-12-801430-1.00004-4. Review.

PMID:
25065887
15.

Life in the Fas lane: differential outcomes of Fas signaling.

Brint E, O'Callaghan G, Houston A.

Cell Mol Life Sci. 2013 Nov;70(21):4085-99. doi: 10.1007/s00018-013-1327-z. Epub 2013 Apr 12. Review.

PMID:
23579628
16.

The FLIP-side of Fas signaling.

Hyer ML, Samuel T, Reed JC.

Clin Cancer Res. 2006 Oct 15;12(20 Pt 1):5929-31. Epub 2006 Oct 6. Review. No abstract available.

17.

Emerging roles for the death adaptor FADD in death receptor avidity and cell cycle regulation.

Werner MH, Wu C, Walsh CM.

Cell Cycle. 2006 Oct;5(20):2332-8. Epub 2006 Oct 16. Review.

PMID:
17102623
18.

Tandem DEDs and CARDs suggest novel mechanisms of signaling complex assembly.

Lo YC, Lin SC, Yang CY, Tung JY.

Apoptosis. 2015 Feb;20(2):124-35. doi: 10.1007/s10495-014-1054-4. Review.

PMID:
25398537
19.
20.

Splice variants in apoptotic pathway.

Miura K, Fujibuchi W, Unno M.

Exp Oncol. 2012 Oct;34(3):212-7. Review.

PMID:
23070006

Supplemental Content

Support Center